Riskpilot← Back to searchSign inGet full accessSYNSENTRUM LADE AS
ASActiveOrg 913756657Haakon Vii'S Gate 9, 7041 TrondheimRetail sale of medical and orthopaedic goods · NACE 4774Est. 201416 employees
Revenue 2024
NOK 24M
+6% vs 2023
EBITDA margin
7.3%
+31% vs 2023
Equity ratio
24.5%
Financial strength
Net profit 2024
NOK 988K
+61% vs 2023
| Revenue | NOK 24M | +6% |
| EBITDA | NOK 1,8M | +31% |
| Net profit | NOK 988K | +61% |
| Total assets | NOK 6,7M | +13% |
| Equity | NOK 1,6M | +13% |
| Employees | 16 | — |
Legal name
SYNSENTRUM LADE AS
Org number
913756657
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
13. juni 2014
Share capital
NOK 200 000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Salg av handelsvarer innen optikk og samt deltagelse i andre virksomheter.
Address
Haakon Vii'S Gate 9, 7041 Trondheim
Phone
+4773929969
Email
lade@no.specsavers.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 14 378 | 18 212 | 20 532 | 22 594 | 24 004 |
| Staff expenses | −4 842 | −5 417 | −6 060 | −7 021 | −7 032 |
| EBITDA | 680 | 1 464 | 1 770 | 1 344 | 1 762 |
| Depreciation & amort. | −610 | −625 | −620 | −606 | −526 |
| EBIT | 70 | 840 | 1 150 | 738 | 1 236 |
| Net financials | −43 | −27 | −21 | 47 | 48 |
| Profit before tax | 27 | 812 | 1 129 | 785 | 1 284 |
| Tax | −0 | 168 | 249 | 173 | 296 |
| Net profit | 27 | 645 | 880 | 612 | 988 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 862 | 5 077 | 6 272 | 5 903 | 6 654 |
| Equity | 785 | 1 430 | 1 430 | 1 442 | 1 630 |
| Long-term debt | 1 440 | 683 | 464 | 75 | 69 |
| Short-term debt | 2 637 | 2 964 | 4 378 | 4 386 | 4 955 |
| Total debt | 4 077 | 3 647 | 4 842 | 4 461 | 5 023 |
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
20202024
Equity ratio
24.5%
This company
38.2%
Market median
-36% vs market
20202024
Return on equity
60.6%
This company
18.4%
Market median
+229% vs market
20202024
Net profit margin
4.1%
This company
8.1%
Market median
-49% vs market
20202024
Asset turnover
3.61×
This company
1.12×
Market median
+222% vs market
20202024
Debt / equity
3.08×
This company
0.62×
Market median
-397% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
IG Deputy Member | Deputy Member | 2014 |
KW Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2014 | |
| Chairman | 2014 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SYNSENTRUM LADE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingvild Gullvåg Wiig | Deputy Member | 0 companies |
| Kjærsti Wiig | Chief Executive Officer | 0 companies |
| Tone Aavik Myhren | Board of Directors | 0 companies |
| John Eyvind Wiig | Chairman | 0 companies |